000 | 01738 a2200493 4500 | ||
---|---|---|---|
005 | 20250515215652.0 | ||
264 | 0 | _c20100927 | |
008 | 201009s 0 0 eng d | ||
022 | _a1095-9327 | ||
024 | 7 |
_a10.1016/j.mcn.2010.03.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSidorova, Yulia A | |
245 | 0 | 0 |
_aPersephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease. _h[electronic resource] |
260 |
_bMolecular and cellular neurosciences _cJul 2010 |
||
300 |
_a223-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiological Assay _xmethods |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xmetabolism |
650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor Receptors _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aNerve Growth Factors _xchemistry |
650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
650 | 0 | 4 |
_aNeurons _xphysiology |
650 | 0 | 4 |
_aParkinson Disease _xtherapy |
650 | 0 | 4 | _aProtein Conformation |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-ret _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
700 | 1 | _aMätlik, Kert | |
700 | 1 | _aPaveliev, Mikhail | |
700 | 1 | _aLindahl, Maria | |
700 | 1 | _aPiranen, Elisa | |
700 | 1 | _aMilbrandt, Jeffrey | |
700 | 1 | _aArumäe, Urmas | |
700 | 1 | _aSaarma, Mart | |
700 | 1 | _aBespalov, Maxim M | |
773 | 0 |
_tMolecular and cellular neurosciences _gvol. 44 _gno. 3 _gp. 223-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mcn.2010.03.009 _zAvailable from publisher's website |
999 |
_c19711443 _d19711443 |